<p>, /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, &#34;SenesTech&#34; 或 &#34;公司&#34;), 作為人道主義害蟲控制解決方案的領導者，今天宣佈任命 Michael Edell 為總裁兼首席執行官，任命自 2026 年 5 月 6 日生效。公司還宣佈了董事會領導層的過渡更新，以支持 SenesTech 下一階段的商業增長和運營執行。</p>
<p>Edell 先生在建立和擴展消費品業務方面擁有良好的業績記錄，具備深厚的電子商務、直銷執行和企業對企業渠道開發的專業知識。董事會相信，Edell 先生的運營和商業經驗使 SenesTech 能夠進一步擴大市場影響力，更高效地拓展收入渠道。</p>
<p>Edell 先生自 2025 年中期以來與 SenesTech 密切合作，最初以顧問身份評估業務並制定以商業增長為重點的戰略計劃。2025 年 10 月，他被任命為臨時首席運營官，負責實施該計劃。自那時以來，他簡化了運營，將直銷收入作為核心增長引擎，並徹底改革了公司的 B2B 過程和組織，以支持更有紀律和可擴展的表現。他還領導了直接管理 Evolve 品牌的老鼠和鼠標產品在亞馬遜銷售的過渡，並加強了在分銷商、全國零售商、市政和其他 B2B 渠道的市場推廣工作。</p>
<p>過去幾個月實施的運營舉措增強了公司的商業基礎設施，使 SenesTech 能夠更高效地擴展。</p>
<p>&#34;Michael 在擔任臨時首席運營官期間展現了高度的紀律性和執行力，&#34; SenesTech 主席 Matthew Szot 説。&#34;他在電子商務、客户參與和銷售渠道開發方面帶來了強大的運營嚴謹性和實踐經驗。董事會相信，這正是 SenesTech 在專注於擴大收入渠道、改善轉化率和建立更可預測、持久的收入模型時所需要的。我們相信 Michael 是推動有紀律的商業執行和長期股東價值創造的合適領導者。&#34;</p>
<p>&#34;我很感激能在這個重要階段領導 SenesTech，並對未來的道路感到興奮，&#34; Edell 先生説。&#34;鑑於我們創新、經過驗證和專利產品的實力，我們相信面前有巨大的機會。我們的優先事項很明確：將資源集中在影響最大的商業機會，改善銷售執行，並建立可擴展的運營流程。我們特別強調直銷和電子商務渠道，包括亞馬遜和我們自己的電子商務平台，在這些渠道中，我們相信數據驅動的營銷、客户教育和直接參與可以推動高效增長。在這些渠道中，我們非常專注於通過訂閲計劃擴大經常性收入，這些計劃已經在進行中並獲得了 traction。同時，我們將繼續與分銷商、害蟲管理專業人士、商業客户和市政當局擴大 B2B 機會。&#34;</p>
<p>&#34;我們相信 Evolve 在一個大型且尚未充分滲透的害蟲管理市場中處於良好位置，因為客户越來越尋求有效和可持續的替代方案。我們的重點是改善執行、擴大認知，並使產品更易於理解、購買和在消費者和專業渠道中部署。我們還計劃通過增加更多的齧齒動物控制產品來擴展 Evolve 品牌，進一步豐富我們的產品線並加強我們在該類別中的地位。我們將繼續專注於有紀律的執行、運營問責和可擴展的增長。&#34;</p>
<p>公司將不再替代 Edell 先生的前臨時首席運營官角色，進一步簡化公司的組織結構和運營模式。</p>
<p>作為領導層過渡的一部分，公司還宣佈了以下董事會更新：</p>
<ul>
<li>Jamie Bechtel 博士將從董事會主席的角色中過渡。與領導層過渡相關，她的臨時執行主席角色已結束。Bechtel 博士將繼續擔任董事會成員，並被任命為提名和公司治理委員會主席以及薪酬委員會主席。</li>
<li>Matthew Szot 被任命為董事會主席。</li>
</ul>
<p>更新後的領導結構反映了董事會對運營執行、問責和強大公司治理的持續關注。</p>
<p><strong>關於 SenesTech, Inc.</strong></p>
<p>SenesTech 致力於通過控制動物害蟲種羣來創造更健康的環境。公司的開創性產品，包括 Evolve 齧齒動物避孕藥，能夠無縫融入害蟲管理計劃，顯著提高其有效性，同時減少對傳統毒藥的依賴。SenesTech 的使命是通過人道、有效和可持續的產品創造更清潔的城市、更高效的企業和更健康的社區。</p>
<p>欲瞭解更多信息，請訪問 https://senestech.com。</p>
<p><strong>安全港聲明</strong></p>
<p>本新聞稿包含根據聯邦證券法定義的前瞻性聲明。前瞻性聲明可能包括關於 Edell 先生任命的預期好處；公司的領導層過渡和董事會任命；公司的戰略、優先事項和計劃；加強電子商務、直接面向消費者、亞馬遜、分銷商、專業、 municipal 和 B2B 銷售渠道的努力；改善銷售執行、客户參與、轉化、運營指標、運營效率、商業效率和市場地位的努力；技術、數據和人工智能工具的使用；以及 Evolve 的潛在增長、採用和商業表現。這些聲明基於當前的預期和假設，並受到可能導致實際結果顯著不同的風險和不確定性的影響。可能導致這些差異的因素包括但不限於現場條件的變化、實施實踐、市場對我們產品的接受度、我們產品的成功商業化、銷售和營銷舉措的有效性、監管考慮以及 SenesTech 在證券交易委員會的文件中描述的其他風險。前瞻性聲明僅在作出之日有效，公司沒有義務更新這些聲明，除非法律要求。</p>
<p><strong>投資者聯繫：</strong></p>
<p>Robert Blum, Lytham Partners, LLC</p>
<p>(602) 889-9700, [email protected]</p>
<p><strong>公司聯繫：</strong> Tom Chesterman, SenesTech, Inc.</p>
<p>(928) 233-7533, [email protected]</p>
<p>來源 SenesTech, Inc.</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTA3Jk5ld3NJdGVtSWQ9TEE1MzUzNyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MDcwODMwUFJfTkVXU19VU1BSX19fX19MQTUzNTM3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTA3Jk5ld3NJdGVtSWQ9TEE1MzUzNyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MDcwODMwUFJfTkVXU19VU1BSX19fX19MQTUzNTM3"/></p>

SNES

2 倍做多納斯達克生物技術 ETF - ProShares

紐交所高增長板生物技術指數 ETF - First Trust

標普生物技術 3 倍做多 - Direxion

納斯達克生物科技指數 ETF - iShares Nasdaq

醫藥突破 ETF - ALPS

動態生物技術與基因組 ETF - Invesco

標普生物技術 ETF - SPDR

生物科技 ETF - VanEck Vectors

<p>SenesTech, Inc. 已任命 Michael Edell 為總裁兼首席執行官，任命自 2026 年 5 月 6 日生效，旨在增強收入增長和運營執行力。Edell 在消費品業務和電子商務方面擁有豐富的背景，計劃專注於直接面向消費者的渠道，並擴大 B2B 機會。領導層的過渡還包括董事會的更新，Matthew Szot 將擔任董事會主席。SenesTech 致力於通過創新和人道的解決方案改善害蟲管理，並旨在加強其市場存在和收入渠道</p>

<p>, /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, &#34;SenesTech&#34; or the &#34;Company&#34;), a leader in humane pest control solutions, today announced the appointment of Michael Edell as President and Chief Executive Officer, effective May 6, 2026. The Company also announced Board leadership transition updates to support SenesTech's next phase of commercial growth and operational execution.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, &#34;SenesTech&#34; 或 &#34;公司&#34;), 作為人道主義害蟲控制解決方案的領導者，今天宣佈任命 Michael Edell 為總裁兼首席執行官，任命自 2026 年 5 月 6 日生效。公司還宣佈了董事會領導層的過渡更新，以支持 SenesTech 下一階段的商業增長和運營執行。</p>
</div><p>Mr. Edell brings a proven track record of building and scaling consumer product businesses, with deep expertise in e-commerce, direct-to-consumer execution, and business-to-business channel development. The Board believes Mr. Edell's operational and commercial experience positions SenesTech to further expand its market presence and scale revenue channels more efficiently.</p>
<div class="lb-trans"><p>Edell 先生在建立和擴展消費品業務方面擁有良好的業績記錄，具備深厚的電子商務、直銷執行和企業對企業渠道開發的專業知識。董事會相信，Edell 先生的運營和商業經驗使 SenesTech 能夠進一步擴大市場影響力，更高效地拓展收入渠道。</p>
</div><p>Mr. Edell has worked closely with SenesTech since mid-2025, initially in a consulting capacity to evaluate the business and develop a strategic plan focused on commercial growth. In October 2025, he was appointed Interim Chief Operating Officer to lead its implementation. Since then, he has streamlined operations, prioritized direct-to-consumer revenue as a core growth engine, and overhauled the Company's B2B processes and organization to support more disciplined and scalable performance. He also led the transition to directly managing Amazon sales of the Evolve brand of Rat and Evolve Mouse products and strengthened go-to-market efforts across distributor, national retailer, municipal, and other B2B channels.</p>
<div class="lb-trans"><p>Edell 先生自 2025 年中期以來與 SenesTech 密切合作，最初以顧問身份評估業務並制定以商業增長為重點的戰略計劃。2025 年 10 月，他被任命為臨時首席運營官，負責實施該計劃。自那時以來，他簡化了運營，將直銷收入作為核心增長引擎，並徹底改革了公司的 B2B 過程和組織，以支持更有紀律和可擴展的表現。他還領導了直接管理 Evolve 品牌的老鼠和鼠標產品在亞馬遜銷售的過渡，並加強了在分銷商、全國零售商、市政和其他 B2B 渠道的市場推廣工作。</p>
</div><p>The operational initiatives implemented over the past several months have strengthened the Company's commercial infrastructure and positioned SenesTech to scale more efficiently.</p>
<div class="lb-trans"><p>過去幾個月實施的運營舉措增強了公司的商業基礎設施，使 SenesTech 能夠更高效地擴展。</p>
</div><p>&#34;Michael has demonstrated a highly disciplined and execution-focused approach during his time as Interim Chief Operating Officer,&#34; said Matthew Szot, Chair of SenesTech. &#34;He brings strong operating rigor and practical experience across e-commerce, customer engagement, and sales channel development. The Board believes this is exactly what SenesTech needs as we focus on scaling revenue channels, improving conversion, and building a more predictable and durable revenue model. We believe Michael is the right leader to drive disciplined commercial execution and long-term stockholder value creation.&#34;</p>
<div class="lb-trans"><p>&#34;Michael 在擔任臨時首席運營官期間展現了高度的紀律性和執行力，&#34; SenesTech 主席 Matthew Szot 説。&#34;他在電子商務、客户參與和銷售渠道開發方面帶來了強大的運營嚴謹性和實踐經驗。董事會相信，這正是 SenesTech 在專注於擴大收入渠道、改善轉化率和建立更可預測、持久的收入模型時所需要的。我們相信 Michael 是推動有紀律的商業執行和長期股東價值創造的合適領導者。&#34;</p>
</div><p>&#34;I appreciate the opportunity to lead SenesTech at this important stage, and I am excited about the path ahead,&#34; said Mr. Edell. &#34;We believe there is a significant opportunity in front of us given the strength of our innovative, proven, and patented products. Our priorities are clear: focus resources on the highest-impact commercial opportunities, improve sales execution, and build scalable operating processes. We are placing particular emphasis on direct-to-consumer and e-commerce channels, including Amazon and our own e-commerce platform, where we believe data-driven marketing, customer education, and direct engagement can drive efficient growth. Within these channels, we are very focused on expanding recurring revenue through subscription programs, which are already underway and gaining traction. At the same time, we will continue to expand B2B opportunities with distributors, pest management professionals, commercial customers, and municipalities.&#34;</p>
<div class="lb-trans"><p>&#34;我很感激能在這個重要階段領導 SenesTech，並對未來的道路感到興奮，&#34; Edell 先生説。&#34;鑑於我們創新、經過驗證和專利產品的實力，我們相信面前有巨大的機會。我們的優先事項很明確：將資源集中在影響最大的商業機會，改善銷售執行，並建立可擴展的運營流程。我們特別強調直銷和電子商務渠道，包括亞馬遜和我們自己的電子商務平台，在這些渠道中，我們相信數據驅動的營銷、客户教育和直接參與可以推動高效增長。在這些渠道中，我們非常專注於通過訂閲計劃擴大經常性收入，這些計劃已經在進行中並獲得了 traction。同時，我們將繼續與分銷商、害蟲管理專業人士、商業客户和市政當局擴大 B2B 機會。&#34;</p>
</div><p>&#34;We believe Evolve is well positioned within a large and underpenetrated pest management market as customers increasingly seek effective and sustainable alternatives. Our focus is on improving execution, expanding awareness, and making the product easier to understand, purchase, and deploy across both consumer and professional channels. We also plan to expand the Evolve brand with additional rodent control products, further broadening our offering and strengthening our position within the category. We remain focused on disciplined execution, operational accountability, and scalable growth.&#34;</p>
<div class="lb-trans"><p>&#34;我們相信 Evolve 在一個大型且尚未充分滲透的害蟲管理市場中處於良好位置，因為客户越來越尋求有效和可持續的替代方案。我們的重點是改善執行、擴大認知，並使產品更易於理解、購買和在消費者和專業渠道中部署。我們還計劃通過增加更多的齧齒動物控制產品來擴展 Evolve 品牌，進一步豐富我們的產品線並加強我們在該類別中的地位。我們將繼續專注於有紀律的執行、運營問責和可擴展的增長。&#34;</p>
</div><p>The Company will not replace Mr. Edell's former Interim Chief Operating Officer role, further streamlining the Company's organizational structure and operating model.</p>
<div class="lb-trans"><p>公司將不再替代 Edell 先生的前臨時首席運營官角色，進一步簡化公司的組織結構和運營模式。</p>
</div><p>As part of the leadership transition, the Company also announced the following Board updates:</p>
<div class="lb-trans"><p>作為領導層過渡的一部分，公司還宣佈了以下董事會更新：</p>
</div><ul>
<li>Dr. Jamie Bechtel will transition from her role as Board Chair. In connection with the leadership transition, her role as Interim Executive Chair has concluded. Dr. Bechtel will continue to serve on the Board and has been appointed Chair of the Nominating and Corporate Governance Committee and Chair of the Compensation Committee.</li>
<li>Matthew Szot has been appointed Board Chair.</li>
</ul>
<div class="lb-trans"><ul>
<li>Jamie Bechtel 博士將從董事會主席的角色中過渡。與領導層過渡相關，她的臨時執行主席角色已結束。Bechtel 博士將繼續擔任董事會成員，並被任命為提名和公司治理委員會主席以及薪酬委員會主席。</li>
<li>Matthew Szot 被任命為董事會主席。</li>
</ul>
</div><p>The updated leadership structure reflects the Board's continued focus on operational execution, accountability, and strong corporate governance.</p>
<div class="lb-trans"><p>更新後的領導結構反映了董事會對運營執行、問責和強大公司治理的持續關注。</p>
</div><p><strong>About SenesTech, Inc.</strong></p>
<div class="lb-trans"><p><strong>關於 SenesTech, Inc.</strong></p>
</div><p>SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The Company's groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are humane, effective and sustainable.</p>
<div class="lb-trans"><p>SenesTech 致力於通過控制動物害蟲種羣來創造更健康的環境。公司的開創性產品，包括 Evolve 齧齒動物避孕藥，能夠無縫融入害蟲管理計劃，顯著提高其有效性，同時減少對傳統毒藥的依賴。SenesTech 的使命是通過人道、有效和可持續的產品創造更清潔的城市、更高效的企業和更健康的社區。</p>
</div><p>For more information, visit https://senestech.com.</p>
<div class="lb-trans"><p>欲瞭解更多信息，請訪問 https://senestech.com。</p>
</div><p><strong>Safe Harbor Statement</strong></p>
<div class="lb-trans"><p><strong>安全港聲明</strong></p>
</div><p>This press release contains forward-looking statements within the meaning of federal securities laws. Forward-looking statements may include statements regarding the anticipated benefits of Mr. Edell's appointment; the Company's leadership transition and Board appointments; the Company's strategy, priorities and plans; efforts to strengthen e-commerce, direct-to-consumer, Amazon, distributor, professional, municipal and B2B sales channels; efforts to improve sales execution, customer engagement, conversion, operating metrics, operational efficiency, commercial efficiency and market position; the use of technology, data and AI-enabled tools; and the potential growth, adoption and commercial performance of Evolve. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Factors that could cause such differences include, among others, variability in field conditions, implementation practices, market acceptance of our products, the successful commercialization of our products, effectiveness of sales and marketing initiatives, regulatory considerations, and other risks described in SenesTech's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them except as required by law.</p>
<div class="lb-trans"><p>本新聞稿包含根據聯邦證券法定義的前瞻性聲明。前瞻性聲明可能包括關於 Edell 先生任命的預期好處；公司的領導層過渡和董事會任命；公司的戰略、優先事項和計劃；加強電子商務、直接面向消費者、亞馬遜、分銷商、專業、 municipal 和 B2B 銷售渠道的努力；改善銷售執行、客户參與、轉化、運營指標、運營效率、商業效率和市場地位的努力；技術、數據和人工智能工具的使用；以及 Evolve 的潛在增長、採用和商業表現。這些聲明基於當前的預期和假設，並受到可能導致實際結果顯著不同的風險和不確定性的影響。可能導致這些差異的因素包括但不限於現場條件的變化、實施實踐、市場對我們產品的接受度、我們產品的成功商業化、銷售和營銷舉措的有效性、監管考慮以及 SenesTech 在證券交易委員會的文件中描述的其他風險。前瞻性聲明僅在作出之日有效，公司沒有義務更新這些聲明，除非法律要求。</p>
</div><p><strong>Investor Contact:</strong></p>
<div class="lb-trans"><p><strong>投資者聯繫：</strong></p>
</div><p>Robert Blum, Lytham Partners, LLC</p>
<div class="lb-trans"><p>Robert Blum, Lytham Partners, LLC</p>
</div><p>(602) 889-9700, [email protected]</p>
<div class="lb-trans"><p>(602) 889-9700, [email protected]</p>
</div><p><strong>Company Contact:</strong> Tom Chesterman, SenesTech, Inc.</p>
<div class="lb-trans"><p><strong>公司聯繫：</strong> Tom Chesterman, SenesTech, Inc.</p>
</div><p>(928) 233-7533, [email protected]</p>
<div class="lb-trans"><p>(928) 233-7533, [email protected]</p>
</div><p>SOURCE SenesTech, Inc.</p>
<div class="lb-trans"><p>來源 SenesTech, Inc.</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTA3Jk5ld3NJdGVtSWQ9TEE1MzUzNyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MDcwODMwUFJfTkVXU19VU1BSX19fX19MQTUzNTM3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA53537&amp;Transmission_Id=202605070830PR_NEWS_USPR_____LA53537&amp;DateId=20260507"/></p>

08:30 ETSenesTech Appoints Michael Edell as President and Chief Executive Officer to Drive Revenue Growth and Scalable Sales Channels

prnewswire

Senestech

08:30 ET SenesTech 任命 Michael Edell 為總裁兼首席執行官，以推動收入增長和拓展可擴展的銷售渠道